Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study
暂无分享,去创建一个
S. Nakai | T. Hamano | M. Abe | J. Hoshino | Atsushi Wada | I. Masakane
[1] D. Schaubel,et al. International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] S. Nakai,et al. Rate of the "burnt-out diabetes" phenomenon in patients on peritoneal dialysis. , 2018, Diabetes research and clinical practice.
[3] T. Hasegawa,et al. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] Gang Liu,et al. Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.
[5] S. Nakai,et al. FP655EFFECTS OF DIALYZER MEMBRANE MATERIALS ON SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS: A 2-YEAR COHORT STUDY FROM THE ANNUAL SURVEY OF THE JAPANESE RENAL DATA REGISTRY , 2018 .
[6] S. Nakai,et al. Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? , 2017, Diabetes research and clinical practice.
[7] S. Nakai,et al. High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry , 2017, American Journal of Nephrology.
[8] D. Rodríguez-Sanz,et al. Footwear used by older people and a history of hyperkeratotic lesions on the foot , 2017, Medicine.
[9] K. Wakai,et al. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013) , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] Chul-woo Yang,et al. Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea , 2015, PloS one.
[11] K. Kalantar-Zadeh,et al. Haemodialysis-induced hypoglycaemia and glycaemic disarrays , 2015, Nature Reviews Nephrology.
[12] M. Abe,et al. Best Practice for Diabetic Patients on Hemodialysis 2012 , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[13] T. Uzu,et al. Glycated Albumin Predicts the Risk of Mortality in Type 2 Diabetic Patients on Hemodialysis: Evaluation of a Target Level for Improving Survival , 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[14] L. Tomlinson,et al. Association Between Glycemia and Mortality in Diabetic Individuals on Renal Replacement Therapy in the U.K. , 2014, Diabetes Care.
[15] R. Bilous,et al. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] Y. Hayashino,et al. Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis. , 2012, Clinical nephrology.
[17] H. Morgenstern,et al. Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population , 2012, Diabetes Care.
[18] B. Freedman. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.
[19] J. Bargman,et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus , 2012, International Urology and Nephrology.
[20] K. Kalantar-Zadeh,et al. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes , 2012, Diabetes.
[21] T. Yoo,et al. Good Glycemic Control Is Associated with Better Survival in Diabetic Patients on Peritoneal Dialysis: A Prospective Observational Study , 2012, PloS one.
[22] M. Rocco,et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[23] K. Kalantar-Zadeh,et al. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[24] K. Kalantar-Zadeh,et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[25] Koichi Matsumoto,et al. Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes? , 2008, Nature Clinical Practice Nephrology.
[26] H. Makino,et al. Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis , 2008, Nephrology.
[27] B. Freedman,et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.
[28] D. Naimark,et al. Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. , 2008, Clinical nephrology.
[29] F. Schmidt. Meta-Analysis , 2008 .
[30] M. Inaba,et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. , 2007, Journal of the American Society of Nephrology : JASN.
[31] J. Minakuchi,et al. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). , 2006, The journal of medical investigation : JMI.
[32] B. Lindholm,et al. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] Mai-Szu Wu,et al. Pre-Dialysis Glycemic Control is An Independent Predictor of Mortality Intype Ii Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[34] T. Nakao,et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. , 1998, Internal medicine.
[35] Mai-Szu Wu,et al. Predialysis Glycemic Control is An Independent Predictor of Clinical Outcome in Type Ii Diabetics on Continuous Ambula Tory Peritoneal Dialysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[36] J. Canham,et al. A matter of life or death. , 1985, Nursing times.
[37] F. Kronenberg,et al. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] S. Nakai,et al. An overview of regular dialysis treatment in Japan (As of December 31, 2012) , 2014 .
[39] Raymond Vanholder,et al. Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2012, Diabetes care.
[40] T. Nakao,et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. , 2007, Internal medicine.